Overview

  • Product name
    (R,S)-Lenalidomide
  • Description
    Thalidomide analog, TNF-α inhibitor
  • Biological description
    Thalidomide (ab120032) analog and TNF-α inhibitor. Potent antitumor and anti-inflammatory effects. Modulates and potentiates host immune responses against multiple myeloma. Active in vitro.
  • Purity
    > 98%

Properties

Associated products

References

This product has been referenced in:
  • Hickey CJ  et al. Lenalidomide-mediated enhanced translation of C/EBPa-p30 protein up-regulates expression of the antileukemic microRNA-181a in acute myeloid leukemia. Blood 121:159-69 (2013). Read more (PubMed: 23100311) »
  • Shiheido H  et al. A phthalimide derivative that inhibits centrosomal clustering is effective on multiple myeloma. PLoS One 7:e38878 (2012). Read more (PubMed: 22761710) »
  • Rozewski DM  et al. Pharmacokinetics and tissue disposition of lenalidomide in mice. AAPS J 14:872-82 (2012). Read more (PubMed: 22956478) »

See 0 Publications for this product

Customer reviews and Q&As

There are currently no Customer reviews or Questions for ab142129.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up